(CC) Chemours - Overview
Sector: Basic MaterialsIndustry: Specialty Chemicals | Exchange NYSE (USA) | Currency USD | Market Cap: 3.058m | Total Return 60.2% in 12m
Stock: Chemicals, Pigments, Resins, Solvents
Total Rating 58
Risk 78
Buy Signal 0.56
| Risk 5d forecast | |
|---|---|
| Volatility | 62.5% |
| Relative Tail Risk | -11.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.96 |
| Alpha | 33.30 |
| Character TTM | |
|---|---|
| Beta | 2.079 |
| Beta Downside | 2.687 |
| Drawdowns 3y | |
|---|---|
| Max DD | 73.60% |
| CAGR/Max DD | -0.09 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
choppy
Description: CC Chemours March 04, 2026
Chemours Company (CC) is a global provider of performance chemicals. The company operates in North America, Asia Pacific, Europe, the Middle East, Africa, and Latin America. It was incorporated in 2014 and is headquartered in Wilmington, Delaware.
Chemours operates through three segments. The Thermal & Specialized Solutions segment offers refrigerants and thermal management solutions, including Freon and Opteon brands. The Titanium Technologies segment produces TiO2 pigment under the Ti-Pure brand, used in coatings and plastics. The Advanced Performance Materials segment provides specialty product solutions, including Teflon and Viton, for diverse industries like electronics and automotive. The diversified chemicals sector is highly sensitive to global economic cycles and raw material costs.
The company utilizes both direct and indirect sales channels, including resellers and distributors. This multi-channel approach is common for chemical companies to reach a broad customer base across various industries. Investors should consider further research on ValueRay to gain deeper insights into Chemours financial health and market position.
Headlines to watch out for
- TiO2 pigment demand impacts Titanium Technologies segment revenue
- Refrigerant sales fluctuate with HVAC and automotive production
- Advanced Performance Materials growth tied to electronics and automotive sectors
- Environmental regulations pose ongoing risk to chemical production
- Raw material costs influence profitability across all segments
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -386.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 13.90 > 1.0 |
| NWC/Revenue: 22.64% < 20% (prev 21.05%; Δ 1.59% < -1%) |
| CFO/TA 0.04 > 3% & CFO 264.0m > Net Income -386.0m |
| Net Debt (3.92b) to EBITDA (181.0m): 21.63 < 3 |
| Current Ratio: 1.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (150.6m) vs 12m ago 0.48% < -2% |
| Gross Margin: 15.53% > 18% (prev 0.20%; Δ 1.53k% > 0.5%) |
| Asset Turnover: 77.98% > 50% (prev 77.33%; Δ 0.65% > 0%) |
| Interest Coverage Ratio: 0.67 > 6 (EBITDA TTM 181.0m / Interest Expense TTM 269.0m) |
Altman Z'' 2.01
| A: 0.18 (Total Current Assets 3.00b - Total Current Liabilities 1.69b) / Total Assets 7.38b |
| B: 0.17 (Retained Earnings 1.22b / Total Assets 7.38b) |
| C: 0.02 (EBIT TTM 181.0m / Avg Total Assets 7.45b) |
| D: 0.14 (Book Value of Equity 978.0m / Total Liabilities 7.13b) |
| Altman-Z'' Score: 2.01 = BBB |
Beneish M -4.00
| DSRI: 0.88 (Receivables 679.0m/770.0m, Revenue 5.81b/5.81b) |
| GMI: 1.28 (GM 15.53% / 19.81%) |
| AQI: -5.64 (AQ_t -0.79 / AQ_t-1 0.14) |
| SGI: 1.00 (Revenue 5.81b / 5.81b) |
| TATA: -0.09 (NI -386.0m - CFO 264.0m) / TA 7.38b) |
| Beneish M-Score: -6.90 (Cap -4..+1) = AAA |
What is the price of CC shares?
As of March 27, 2026, the stock is trading at USD 21.58 with a total of 4,020,305 shares traded.
Over the past week, the price has changed by +13.94%, over one month by +25.23%, over three months by +79.41% and over the past year by +60.17%.
Over the past week, the price has changed by +13.94%, over one month by +25.23%, over three months by +79.41% and over the past year by +60.17%.
Is CC a buy, sell or hold?
Chemours has received a consensus analysts rating of 3.80.
Therefor, it is recommend to hold CC.
- StrongBuy: 3
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19.3 | -10.4% |
| Analysts Target Price | 19.3 | -10.4% |
CC Fundamental Data Overview March 26, 2026
P/E Forward = 11.3122
P/S = 0.5265
P/B = 10.6279
P/EG = 1.6685
Revenue TTM = 5.81b USD
EBIT TTM = 181.0m USD
EBITDA TTM = 181.0m USD
Long Term Debt = 4.10b USD (from longTermDebt, last quarter)
Short Term Debt = 104.0m USD (from shortTermDebt, last quarter)
Debt = 4.58b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.92b USD (from netDebt column, last quarter)
Enterprise Value = 6.97b USD (3.06b + Debt 4.58b - CCE 670.0m)
Interest Coverage Ratio = 0.67 (Ebit TTM 181.0m / Interest Expense TTM 269.0m)
EV/FCF = 136.7x (Enterprise Value 6.97b / FCF TTM 51.0m)
FCF Yield = 0.73% (FCF TTM 51.0m / Enterprise Value 6.97b)
FCF Margin = 0.88% (FCF TTM 51.0m / Revenue TTM 5.81b)
Net Margin = -6.65% (Net Income TTM -386.0m / Revenue TTM 5.81b)
Gross Margin = 15.53% ((Revenue TTM 5.81b - Cost of Revenue TTM 4.91b) / Revenue TTM)
Gross Margin QoQ = 11.50% (prev 15.72%)
Tobins Q-Ratio = 0.94 (Enterprise Value 6.97b / Total Assets 7.38b)
Interest Expense / Debt = 1.50% (Interest Expense 69.0m / Debt 4.58b)
Taxrate = 21.0% (US default 21%)
NOPAT = 143.0m (EBIT 181.0m * (1 - 21.00%))
Current Ratio = 1.78 (Total Current Assets 3.00b / Total Current Liabilities 1.69b)
Debt / Equity = 18.34 (Debt 4.58b / totalStockholderEquity, last quarter 250.0m)
Debt / EBITDA = 21.63 (Net Debt 3.92b / EBITDA 181.0m)
Debt / FCF = 76.76 (Net Debt 3.92b / FCF TTM 51.0m)
Total Stockholder Equity = 341.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -5.18% (Net Income -386.0m / Total Assets 7.38b)
RoE = -113.2% (Net Income TTM -386.0m / Total Stockholder Equity 341.0m)
RoCE = 4.08% (EBIT 181.0m / Capital Employed (Equity 341.0m + L.T.Debt 4.10b))
RoIC = 3.19% (NOPAT 143.0m / Invested Capital 4.48b)
WACC = 6.03% (E(3.06b)/V(7.64b) * Re(13.30%) + D(4.58b)/V(7.64b) * Rd(1.50%) * (1-Tc(0.21)))
Discount Rate = 13.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.66%
[DCF] Terminal Value 80.63% ; FCFF base≈51.0m ; Y1≈33.5m ; Y5≈15.3m
[DCF] Fair Price = N/A (negative equity: EV 480.9m - Net Debt 3.92b = -3.43b; debt exceeds intrinsic value)
EPS Correlation: -55.45 | EPS CAGR: -59.33% | SUE: -0.23 | # QB: 0
Revenue Correlation: -59.32 | Revenue CAGR: -7.25% | SUE: 0.27 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.64 | Chg7d=+0.006 | Chg30d=-0.001 | Revisions Net=+1 | Analysts=8
EPS current Year (2026-12-31): EPS=1.42 | Chg7d=+0.015 | Chg30d=-0.305 | Revisions Net=-7 | Growth EPS=+49.7% | Growth Revenue=+2.9%
EPS next Year (2027-12-31): EPS=2.23 | Chg7d=+0.017 | Chg30d=-0.137 | Revisions Net=-8 | Growth EPS=+56.6% | Growth Revenue=+5.7%
[Analyst] Revisions Ratio: +0.20 (3 Up / 2 Down within 30d for Next Quarter)
P/S = 0.5265
P/B = 10.6279
P/EG = 1.6685
Revenue TTM = 5.81b USD
EBIT TTM = 181.0m USD
EBITDA TTM = 181.0m USD
Long Term Debt = 4.10b USD (from longTermDebt, last quarter)
Short Term Debt = 104.0m USD (from shortTermDebt, last quarter)
Debt = 4.58b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.92b USD (from netDebt column, last quarter)
Enterprise Value = 6.97b USD (3.06b + Debt 4.58b - CCE 670.0m)
Interest Coverage Ratio = 0.67 (Ebit TTM 181.0m / Interest Expense TTM 269.0m)
EV/FCF = 136.7x (Enterprise Value 6.97b / FCF TTM 51.0m)
FCF Yield = 0.73% (FCF TTM 51.0m / Enterprise Value 6.97b)
FCF Margin = 0.88% (FCF TTM 51.0m / Revenue TTM 5.81b)
Net Margin = -6.65% (Net Income TTM -386.0m / Revenue TTM 5.81b)
Gross Margin = 15.53% ((Revenue TTM 5.81b - Cost of Revenue TTM 4.91b) / Revenue TTM)
Gross Margin QoQ = 11.50% (prev 15.72%)
Tobins Q-Ratio = 0.94 (Enterprise Value 6.97b / Total Assets 7.38b)
Interest Expense / Debt = 1.50% (Interest Expense 69.0m / Debt 4.58b)
Taxrate = 21.0% (US default 21%)
NOPAT = 143.0m (EBIT 181.0m * (1 - 21.00%))
Current Ratio = 1.78 (Total Current Assets 3.00b / Total Current Liabilities 1.69b)
Debt / Equity = 18.34 (Debt 4.58b / totalStockholderEquity, last quarter 250.0m)
Debt / EBITDA = 21.63 (Net Debt 3.92b / EBITDA 181.0m)
Debt / FCF = 76.76 (Net Debt 3.92b / FCF TTM 51.0m)
Total Stockholder Equity = 341.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -5.18% (Net Income -386.0m / Total Assets 7.38b)
RoE = -113.2% (Net Income TTM -386.0m / Total Stockholder Equity 341.0m)
RoCE = 4.08% (EBIT 181.0m / Capital Employed (Equity 341.0m + L.T.Debt 4.10b))
RoIC = 3.19% (NOPAT 143.0m / Invested Capital 4.48b)
WACC = 6.03% (E(3.06b)/V(7.64b) * Re(13.30%) + D(4.58b)/V(7.64b) * Rd(1.50%) * (1-Tc(0.21)))
Discount Rate = 13.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.66%
[DCF] Terminal Value 80.63% ; FCFF base≈51.0m ; Y1≈33.5m ; Y5≈15.3m
[DCF] Fair Price = N/A (negative equity: EV 480.9m - Net Debt 3.92b = -3.43b; debt exceeds intrinsic value)
EPS Correlation: -55.45 | EPS CAGR: -59.33% | SUE: -0.23 | # QB: 0
Revenue Correlation: -59.32 | Revenue CAGR: -7.25% | SUE: 0.27 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.64 | Chg7d=+0.006 | Chg30d=-0.001 | Revisions Net=+1 | Analysts=8
EPS current Year (2026-12-31): EPS=1.42 | Chg7d=+0.015 | Chg30d=-0.305 | Revisions Net=-7 | Growth EPS=+49.7% | Growth Revenue=+2.9%
EPS next Year (2027-12-31): EPS=2.23 | Chg7d=+0.017 | Chg30d=-0.137 | Revisions Net=-8 | Growth EPS=+56.6% | Growth Revenue=+5.7%
[Analyst] Revisions Ratio: +0.20 (3 Up / 2 Down within 30d for Next Quarter)